Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly those targeting central nervous system disorders. Its structure supports the development of neuroprotective agents and has been explored in research on anti-Parkinson’s and anti-Alzheimer’s drug candidates. The compound's ability to cross the blood-brain barrier enhances its utility in designing nootropic and neuroregenerative therapies. Additionally, it serves as a building block in medicinal chemistry for creating thiazolidine-based bioactive molecules with antioxidant and anti-inflammatory properties.